Acmeglim MV 1 Tablet is a combination of Glimepiride, Metformin and Voglibose which belongs to the group of medicines called Antidiabetic Agents. Acmeglim MV 1 Tablet is used in adults to treat type 2 diabetes mellitus when diet, exercise and single agents/ second line therapy with two drugs are insufficient to adequately control blood sugar level.
Acmeglim MV 1 Tablet is not recommended for use in patients allergic to glimepiride, metformin, Voglibose, and/or other sulfonylureas/sulphonamides. It is also not recommended for use in patients with acute conditions (such as dehydration, severe infection), severe ketosis (severe complication of diabetes), severe trauma, lung problems (such as acute/chronic respiratory failure), heart problems (such as acute/chronic cardiac failure, recent myocardial infarction), and/or severe kidney/liver problems.
Before taking Acmeglim MV 1 Tablet, inform your doctor if you recently had trauma, and/or have febrile infections, fever, uncontrolled diabetes, hypothyroidism (underactive thyroid), chronic intestinal disease, fever, other kidney/liver problems.
Acmeglim MV 1 Tablet is not recommended for use in pregnant and breastfeeding women since it may cause harm to the developing foetus/nursing child.
Acmeglim MV 1 Tablet is also not recommended for use in children and adolescents (aged below 18 years) and is advised to be used with caution in elderly patients (aged 75 years/above) after consulting the doctor.
The most common side-effects of Acmeglim MV 1 Tablet are nausea and vomiting, diarrhoea, abdominal pain, loss of appetite, metallic taste, and/or hypoglycaemia (low blood sugar). Consult your doctor if any of these side effects worsens.
Uses of Acmeglim MV 1
Treats type 2 diabetes mellitus in adults when diet, exercise and single agents/ second line of therapy with two drugs are insufficient to adequately control blood sugar level
How Does Acmeglim MV 1 Works
Acmeglim MV 1 Tablet treats type 2 diabetes mellitus, where Glimepiride lowers blood glucose level by increasing the amount of insulin released by the pancreas, Metformin delays glucose absorption from intestines which results in low glucose production in liver thus increasing body’s response to restore insulin, and Voglibose prevents blood glucose level to raise high after meals by breaking down complex sugars into simple sugars (such as glucose) thus resulting in the control of blood glucose level due to type 2 diabetes mellitus in affected individuals.
Side Effects of Acmeglim MV 1
Hypoglycemia (low blood sugar levels)
Allergic reactions (rash, itching, swelling)
Changes in taste sensation
Muscle pain or weakness
Increased risk of upper respiratory tract infections
Common Side Effects
Nausea, vomiting, diarrhoea, abdominal pain, loss of appetite
Hypoglycaemia (low blood sugar)
Rare Side Effects
Signs of hypersensitivity reaction such as rash, itching
Dosage of Acmeglim MV 1
The recommended dosage of Acmeglim MV 1 is one tablet per day.
Take the tablet with a meal or as directed by your healthcare provider.
Do not exceed the prescribed dose unless instructed by your doctor.
Follow your doctor’s instructions regarding the duration of treatment